| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PY17X_0907300
|
| Gene Model P. falciparum ortholog |
PF3D7_1143100
|
| Gene product | AP2 domain transcription factor AP2-O, putative |
| Gene product: Alternative name | ApiAP2; AP2-O |
| top of page |
| Details of the genetic modification |
| Name of the tag | GFPmut2 |
| Details of tagging | C-terminal |
| Additional remarks: tagging | |
| Commercial source of tag-antibodies | |
| Type of plasmid/construct | (Linear) plasmid double cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
|
| Selectable marker used to select the mutant parasite | hdhfr |
| Promoter of the selectable marker | eef1a |
| Selection (positive) procedure | pyrimethamine |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | Generation and Validation of Transgenic Parasite Lines: Transgenic Plasmodium yoelii (17XNL strain) parasite lines were created using conventional reverse genetics approaches with specific targeting regions for double homologous recombination for each tagged line. Targeting regions for the coding sequence (CDS) and 3’ UTR of target genes were PCR amplified from wild-type Py17XNL genomic DNA and combined into a single amplicon by sequence overlap extension (SOE) PCR. This amplicon was inserted into an intermediate plasmid (pCR-Blunt) for initial sequence verification of the target regions. The targeting regions were then inserted into a final pDEF plasmid vector containing the coding sequence for GFPmut2, or TurboID and GFPmut2, with the P. berghei DHFR 3’ UTR, and the human DHFR drug resistance cassette. The final plasmids were linearized and transfected into Accudenz-purified P. yoelii schizonts produced in ex vivo cultures. |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | |
| Additional information primer 1 | |
| Sequence Primer 2 | |
| Additional information primer 2 | |
| Sequence Primer 3 | |
| Additional information primer 3 | |
| Sequence Primer 4 | |
| Additional information primer 4 | |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
|
| top of page |